TURNER DANIEL K III 4
4 · Orexigen Therapeutics, Inc. · Filed Dec 17, 2009
Insider Transaction Report
Form 4
TURNER DANIEL K III
Director
Transactions
- Sale
Common Stock
2009-12-17$7.55/sh−100,000$755,000→ 1,198,712 total(indirect: By Montreux Equity Partners II, SBIC, LP, Montreux Equity Partners III, SBIC, LP and related funds)
Footnotes (3)
- [F1]All 100,000 shares sold were sold by Montreux Equity Partners III SBIC, L.P.
- [F2]Of the total 1,198,712 total shares beneficially owned following the reported transaction, 499,356 shares are held by Montreux Equity Partners II SBIC, L.P. and 699,356 shares are held by Montreux Equity Partners III SBIC, L.P.
- [F3]The reported securities are owned directly by Montreux Equity Partners II SBIC, L.P., ("MEP II") and Montreux Equity Partners III SBIC, L.P, ("MEP III"). The voting and disposition of the shares held by MEP II and MEP III are determined by Montreux Equity Management II SBIC, LLC, ("MEM II") and Montreux Equity Management III SBIC, LLC, ("MEM III"), respectively. Mr. Turner is a managing member of MEM II and MEM III. Mr. Turner disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.